Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis

Por Lycke, J, Karlsson, J, Andersen, O, Rosengren, L
Publicado em 1998

Brain tumours in Sweden 1996: care and costs

Por Blomqvist, P, Lycke, J, Strang, P, Tornqvist, H, Ekbom, A
Publicado em 2000

A nationwide survey of the influence of month of birth on the risk of developing multiple sclerosis in Sweden and Iceland

Por Eliasdottir, Olöf, Hildeman, Anders, Longfils, Marco, Nerman, O., Lycke, J.
Publicado no J Neurol (2017)

Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.

Por Vrethem, M, Skogh, T, Ernerudh, J, Ekstedt, B, Andersen, O, Lycke, J
Publicado em 1993

Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.

Por Horal, P, Hall, W W, Svennerholm, B, Lycke, J, Jeansson, S, Rymo, L, Kaplan, M H, Vahlne, A
Publicado em 1991

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

Por Tedeholm, H, Lycke, J, Skoog, B, Lisovskaja, V, Hillert, J, Dahle, C, Fagius, J, Fredrikson, S, Landtblom, A-M, Malmeström, C, Martin, C, Piehl, F, Runmarker, B, Stawiarz, L, Vrethem, M, Nerman, O, Andersen, O
Publicado em 2013

Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association...

Por Vågberg, M., Axelsson, M., Birgander, R., Burman, J., Cananau, C., Forslin, Y., Granberg, T., Gunnarsson, M., von Heijne, A., Jönsson, L., Karrenbauer, V. D., Larsson, E.‐M., Lindqvist, T., Lycke, J., Lönn, L., Mentesidou, E., Müller, S., Nilsson, P., Piehl, F., Svenningsson, A., Vrethem, M., Wikström, J.
Publicado no Acta Neurol Scand (2016)